Adriana Matutino Kahn
Advertisement
Articles by Adriana Matutino Kahn
Advertisement
Latest Updated Articles
13 Assessing Intratumor Heterogeneity in Programmed Death-Ligand 1 (PD-L1) Protein Expression in Early-Stage Breast CancerPublished: April 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma
2
How ADCs are Replacing Chemotherapy as Breast Cancer Treatment
3
What Were The Most Impactful GU Oncology Data From ESMO 2025?
4
Daratumumab Approval May Be “Game Changer” in High-Risk Smoldering Myeloma
5
